KBS India (530357)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹8.26 |
| Market Cap | ₹89.38 Cr |
| P/E Ratio | 57.12 |
| ROCE | 1.36% |
| ROE | 0.74% |
| Dividend Yield | 0% |
| Profit Growth | -1,300% |
| Debt/Equity | — |
| Sales Growth | -6.9% |
| 52-Week Range | ₹1.02 — ₹8.26 |
| Sector | Finance |
| Book Value | ₹3.3 |
Strengths
- Book value of ₹3.30 per share provides some tangible asset backing, though the stock trades well above it.
- Latest quarter still shows ₹1 Cr of sales, indicating the business is not entirely dormant.
- Small market cap of ₹89 Cr means a relatively modest absolute improvement in profits could have a large percentage impact on earnings.
- As an NSE/BSE-listed entity, there is a framework for public disclosure and retail participation.
Concerns
- P/E of 57.12 and P/B of 2.50 are far too rich for a business generating ROE of just 0.74% and ROCE of 1.36%.
- Profit growth of -1,300%, sales growth of -6.9%, and a Piotroski F-score of 3/9 point to serious fundamental deterioration.
- Latest quarter net profit is around zero, and dividend yield is 0%, so there is no earnings or income support for the valuation.
- Promoter holding and debt/equity are unavailable, leaving critical ownership and leverage questions unanswered.
AI Analysis
Let me start with the simple facts. KBS India sells at ₹8.26, the very top of its 52-week range of ₹1.02 to ₹8.26. The market cap is ₹89 Cr. But price is not the same as value. What would I own? A small 'Other Financial Services' company with latest quarterly sales of only ₹1 Cr, and net profit of roughly ₹0 Cr. Sales growth is -6.9%, and reported profit growth is -1,300%. Those are not numbers of a compounder; they are numbers of a business in trouble. I insist on durable competitive advantages. I see no moat here. I also insist on intelligent capital allocation. With ROE at 0.74% and ROCE at 1.36%, shareholders are earning almost nothing on their equity. A 57.12 P/E and 2.50 P/B are prices Mr. Market charges when he believes in a rosy future. The balance sheet shows book value of ₹3.30 per share, so at ₹8.26 I am paying two and a half times tangible book for a business earning less than one percent on equity. There is no dividend yield — zero — to compensate for the wait. The Piotroski score of 3 out of 9 also signals deep fundamental weakness in profitability, leverage, and efficiency. Debt/equity and promoter holding are not available, which leaves too many unanswered questions for a prudent investor. In Graham's terms, every investment should have a margin of safety. Here, the margin of safety is absent; the price already reflects optimistic expectations. I cannot classify this as a wonderful business at a fair price. It is a weak business at a rich price. If a genuine turnaround happens, earnings will have to improve dramatically and be visible in quarterly reports. Until then, this looks more like a speculation than an investment. I would watch from the sidelines.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer